Lifevantage director buys 976 shares at $6.22

A Lifevantage Corp director increased his direct holdings through a Rule 10b5-1 plan purchase.

Rhea-AI Filing Summary

Lifevantage Corp (LFVN) reports that director Lewis Darwin purchased common stock in the company. On September 15, 2026, he bought 976 shares at $6.22 per share in an open-market or private transaction, increasing his directly held stake to 138,244 shares. The filing affirms that this trade was made under a Rule 10b5-1 trading plan.

Insider Trade Summary 10b5-1

Net Buyer: 976 shares

Net Buy 1 txn

Insider Lewis Darwin

Role Director

Bought 976 shs ($6K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	976	$6.22	$6K

Holdings After Transaction: Common Stock — 138,244 shares (Direct)

Key Figures

Shares purchased: 976 shares Purchase price per share: $6.22 per share Direct holdings after transaction: 138,244 shares

3 metrics

Shares purchased 976 shares Common stock acquired by director Lewis Darwin on September 15, 2026

Purchase price per share $6.22 per share Price paid for Lifevantage Corp common stock on September 15, 2026

Direct holdings after transaction 138,244 shares Lewis Darwin’s directly held Lifevantage Corp common stock following the reported purchase

Key Terms

Rule 10b5-1 trading plan, open-market or private transaction

2 terms

Rule 10b5-1 trading plan regulatory

"The filing affirms that this trade was made under a Rule 10b5-1 trading plan."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market or private transaction financial

"He bought 976 shares at $6.22 per share in an open-market or private transaction."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LFVN report for director Lewis Darwin?

Lifevantage Corp reported that director Lewis Darwin purchased 976 shares of its common stock on September 15, 2026 at a price of $6.22 per share in an open-market or private transaction, increasing his reported direct ownership.

How many LFVN shares does Lewis Darwin hold after this reported purchase?

After the reported purchase, Lewis Darwin directly holds 138,244 shares of Lifevantage Corp common stock. This figure reflects his position immediately following the September 15, 2026 acquisition of 976 shares disclosed in the Form 4.

Was the LFVN insider trade by Lewis Darwin under a Rule 10b5-1 trading plan?

Yes. The Form 4 affirms that the reported transaction by director Lewis Darwin was made under a Rule 10b5-1 trading plan, indicating it followed a pre-arranged trading program rather than ad hoc trading decisions.

What price did Lewis Darwin pay for LFVN shares in this Form 4 filing?

Lewis Darwin paid $6.22 per share for 976 shares of Lifevantage Corp common stock on September 15, 2026, according to the Form 4, in a reported open-market or private purchase transaction.

Is the reported LFVN insider activity a purchase or a sale?

The reported insider activity is a purchase. Director Lewis Darwin acquired 976 shares of Lifevantage Corp common stock on September 15, 2026, increasing his directly held position to 138,244 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:05 PM Accepted by SEC EDGAR 09/17/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lewis Darwin

(Last) (First) (Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI UTAH 84043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2026		P		976	A	$6.22	138,244	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Darwin Lewis	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)